Answers are grounded in this paper and cite their sources.
This Viewpoint describes current evidence regarding adverse events associated with isotretinoin therapy and recommends limiting routine laboratory monitoring for patients receiving the therapy.
No takes yet. Share an insight, caveat, or question.
Pierson et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: